Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
ED50 of dexmedetomidine for general anesthesia induction in abdominal surgery
ChiCTR2200055246Phase 4Recruiting
- Sponsor
- Cancer Hospital, Chinese Academy of Medical Sciences
- Start
- Jan 2022
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, open-label, single-arm trial of dexmedetomidine in cancer and None, sponsored by Cancer Hospital, Chinese Academy of Medical Sciences. Primary endpoint: ED50 of dexmedetomidine for induction of general anesthesia. Started Jan 2022; status: recruiting.
02
Drugs
dexmedetomidine
03
Conditions
cancer
Beyond the preview
Go deeper on ChiCTR2200055246.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR2200055246.